Agenda Topics- Cancer Biology and Stem Cell Signalling
- Cardiac iPSCs for Drug Discovery
- Developments from the EBiSC
- Disease Modelling and Phenotypic Drug Screening
- Partnering; Academia, Hospitals and Pharma
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to dateTimothy Allsopp, Co-ordinator IMI EBiSC Project, Pfizer Zameel Cader, Director and Principal Scientist, IMI StemBANCC, University of Oxford Davide Danovi, Director, Cell Phenotyping Platform, Kings College London Faye Drawnel, Scientist, Pharma Research and Early Development, Roche Lauren Drowley, Associate Principal Scientist, AstraZeneca Gary Gintant, Senior Research Fellow, Abbvie David Hay, Chair of Tissue Engineering, MRC Centre for Regenerative Medicine, University of Edinburgh Dietmar Hess, Lab Leader, Axiogenesis AG Dominic Hussey, Senior Account Manager, Cellular Dynamics International Inc Lorenz Mayr, Vice President, AstraZeneca Ltd Francesco Saverio Tedesco, Principal Research Associate, University College London Tristan Thwaites, Business Development & Product Specialist, Axol Bioscience Chris Ward, Senior Lecturer, University of Manchester Joseph Wu, Director/Professor, Stanford University School of Medicine Xianmin Zeng, Associate Professor, Buck Institute for Research on Aging
|